Reader's
Guide
to
the
Malathion
E­
Docket
#
OPP­
2004­
0348
10/
07/
05
EPA
has
created
this
document
to
provide
an
organizational
structure
to
the
Malathion
e­
docket.
The
docket
index
lists
items
sequentially,
while
this
document
lists
them
by
subject
matter.
The
Agency
is
providing
the
"
Reader's
Guide"
to
allow
the
reader
to
more
easily
access
and
navigate
the
various
items
contained
in
the
Malathion
e­
docket.

Risk
Assessment
Documents
Docket
Item
No.
Subject
4
Revised
Human
Health
Risk
Assessment
5
Dietary
risk
assessment
support
document
6
Residential
risk
assessment
support
document
(
Table
2
corrected
10/
07/
2005)
10
­
14
Occupational
risk
assessment
support
document
(
Table
2
of
Docket
item
#
10
corrected
10/
07/
2005)
15
Benchmark
Dose
Analysis
supporting
document
16
Comparative
Toxicity
and
Adjustment
Factor
supporting
document
17
Human
(
poisoning)
incidents
document
18
­
20
Drinking
water
exposure
documents
21
­
25
Ecological
Fate
and
Effects
Chapter
2000
and
supporting
documents
27
EPA
Document
on
Pesticide
and
Pharmaceutical
Co­
exposure
34
EPA
Response
to
Dr.
Dementi's
Dissenting
Opinion
U.
S
Department
of
Agriculture
Documents
8
Operational
procedures
of
the
Boll
Weevil
Eradication
Program
29
Status
of
Boll
Weevil
Eradication
Program
U.
S.
Food
and
Drug
Administration
Documents
Docket
Item
No.
Subject
26
FDA
review
of
Ovide
Lotion
28
FDA
memorandum
to
EPA
on
co­
exposure
Dissenting
Opinion
Documents
of
Dr.
Brian
Dementi
Docket
items
30
­
33
are
documents
submitted
by
Dr.
Brian
Dementi
in
support
of
his
dissenting
opinion
on
elements
of
the
malathion
risk
assessment.
The
human
health
risk
assessment
document
submitted
in
connection
with
Dr.
Dementi's
comments
is
a
draft
document,
and
differs
from
the
final
Revised
Malathion
Risk
Assessment
which
is
listed
as
item
number
4.
EPA's
official
response
to
Dr.
Dementi's
comments
are
contained
in
Item
number
34.

Docket
Item
No.
Subject
30
­
33
Dissenting
Opinion
of
Dr.
Dementi
*
Place
holders
for
document
numbers
7,
and
9,
have
intentionally
been
left
blank.
